Search results for "Terminal"

showing 10 items of 364 documents

Pattern and characteristics of advanced cancer patients admitted to hospices in Italy

2013

Abstract The aim of this multicenter study was to assess the pattern and the characteristics of advanced cancer patients admitted to hospices. A consecutive sample of patients admitted in a period of 6 months was taken into consideration. Two hundred thirty-six patients admitted to hospices were consecutively assessed. Ninety-six percent of patients were admitted in acute hospital in the previous 3 months, with a mean time spent in hospital of 34.5 days, and 47 % of patients had received chemotherapy the month before hospice admission. Thirty-four percent of patients for whom data were available had significant persistent pain, and 44 % of them presented episodes of breakthrough pain. Sixty…

AdultMalemedicine.medical_specialtyPalliative caredescriptive studyPain medicineSettore MED/42 - Igiene Generale E ApplicataFentanyladvanced cancer patientNeoplasmsOutcome Assessment Health CaremedicineHumansProspective StudiesIntensive care medicineProspective cohort studySurvival analysisAgedadvanced cancer patients; hospice; descriptive studyAged 80 and overTerminal CareMarital Statusbusiness.industryNursing researchPalliative CareHospicesLength of StayMiddle AgedSurvival AnalysisAnalgesics OpioidLogistic ModelsOncologyOpioidItalyhospiceEmergency medicineMarital statusFemalebusinessmedicine.drug
researchProduct

Association of simvastatin and hyperlipidemia with periodontal status and bone metabolism markers.

2014

Background: The objective of this study is to determine whether simvastatin consumption and hyperlipidemia are associated with a worse periodontal condition and specific bone activity biomarkers. Methods: This cross-sectional and analytic study includes 73 patients divided into three groups: 1) simvastatin-treated patients with hyperlipidemia (n = 29); 2) patients with hyperlipidemia treated by diet alone (n = 28); and 3) normolipidemic patients (controls, n = 16). The periodontal clinical variables of all participants were gathered, a blood sample was drawn from each to determine the lipid profile (total cholesterol, triglycerides, low-density lipoprotein, and high-density lipoprotein), se…

AdultMalemedicine.medical_specialtySimvastatinAlcohol DrinkingOsteocalcinHyperlipidemiasBlood SedimentationCollagen Type IBone remodelingN-terminal telopeptideInternal medicineHyperlipidemiaPeriodontal Attachment LossmedicineHumansTriglyceridesAgedHypolipidemic AgentsPeriodontitismedicine.diagnostic_testbusiness.industryCholesterol HDLSmokingOsteoprotegerinnutritional and metabolic diseasesCholesterol LDLMiddle Agedmedicine.diseasePeptide FragmentsEndocrinologyC-Reactive ProteinCholesterolCross-Sectional StudiesClinical attachment lossSimvastatinErythrocyte sedimentation ratePeriodonticsFemaleHydroxymethylglutaryl-CoA Reductase InhibitorsPeriodontal IndexbusinessLipid profilePeptidesBiomarkersProcollagenmedicine.drugJournal of periodontology
researchProduct

Effect of long-term treatment with GH on bone metabolism, bone mineral density and bone elasticity in GH-deficient adults

1998

OBJECTIVE Adults with GH deficiency (GHD) commonly have subnormal bone mineral density (BMD), and have been reported to have an increased risk of fractures. It has been suggested that GH replacement therapy may have beneficial effects on bone in such patients. The aim of this study was to investigate the effects of long-term GH replacement therapy on bone metabolism, BMD and bone elasticity in adults with GHD. DESIGN At the start of the study, 20 adults with GHD were randomized to receive either GH, 0.25 IU/kg/week (the ‘GH group’) or placebo (the ‘placebo group’). After 6 months, patients in the placebo group were switched to GH therapy, and all patients received GH for a further 42 months…

AdultMalemedicine.medical_specialtyTime FactorsEndocrinology Diabetes and MetabolismPlaceboBone and BonesCollagen Type IBone resorptionBone remodelingGrowth hormone deficiencylaw.inventionAbsorptiometry PhotonEndocrinologyN-terminal telopeptideForearmRandomized controlled trialBone DensitylawInternal medicineHumansMedicineBone mineralbusiness.industryMiddle Agedmedicine.diseaseElasticityPeptide Fragmentsmedicine.anatomical_structureEndocrinologyGrowth HormoneFemaleCollagenPeptidesbusinessBiomarkersProcollagenClinical Endocrinology
researchProduct

Risk factors for clinical stress fractures in male military recruits: A prospective cohort study

2004

This prospective study was aimed at evaluating risk factors for symptomatic stress fractures among 179 Finnish male military recruits, aged 18 to 20 years. The subjects were studied in the very beginning of the military service of 6 to 12 months in summer. Bone mineral content (BMC) and density (BMD) were measured by dual energy X-ray absorptiometry (DXA) at the lumbar spine and at the hip and heel ultrasound investigation was performed. Blood was sampled for determination of serum total and free testosterone, total and free estradiol, sex hormone-binding globulin (SHBG), procollagen type I N propeptide, total and carboxylated osteocalcin, tartrate-resistant acid phosphatase 5b, 25-hydroxyv…

AdultMalemusculoskeletal diseasesmedicine.medical_specialtyHistologyAdolescentFractures StressBone densityPhysiologyEndocrinology Diabetes and MetabolismAcid PhosphataseOsteocalcinParathyroid hormoneCollagen Type IBone remodelingSex hormone-binding globulinN-terminal telopeptideBone DensityRisk FactorsSex Hormone-Binding GlobulinInternal medicinemedicineHumansTestosteroneProspective StudiesVitamin DProspective cohort studyFemoral neckPolymorphism GeneticStress fracturesEstradiolbiologyTartrate-Resistant Acid Phosphatasebusiness.industrymedicine.diseaseIsoenzymesMilitary Personnelmedicine.anatomical_structureEndocrinologyReceptors EstrogenParathyroid HormoneReceptors Androgenbiology.proteinbusinessBone
researchProduct

Biochemical bone markers compared with bone density measurement by dual energy X-ray absorptiometry

1995

In contrast to medical imaging, the biochemical markers allow a more frequent determination and are not as invasive as histomorphometric methods. We investigated biochemical markers of type I collagen compared with bone density measurements in 85 females between 41 and 89 years of age (median: 57 years). The bone density measurements were performed by dual energy X-ray absorptiometry (DXA) on the lumbar spine (L1-4). The bone density measurements were stated as a percentage of the norm. All patients were divided into three groups: I =80%; II = 80-130%; III =120%. Based on this classification the median concentration of the I-carboxyterminal propeptide of type I collagen in serum (S-PICP) as…

AdultPathologymedicine.medical_specialtyAnabolismBone densityEndocrinology Diabetes and MetabolismBone and BonesCollagen Type IBone remodelingAbsorptiometry PhotonEndocrinologyN-terminal telopeptideBone DensityInternal medicinemedicineHumansOrthopedics and Sports MedicineDual-energy X-ray absorptiometryAgedAged 80 and overbiologymedicine.diagnostic_testChemistryLiterMiddle AgedPeptide FragmentsEndocrinologyOsteocalcinbiology.proteinRegression AnalysisFemaleCollagenPeptidesBiomarkersProcollagenType I collagenCalcified Tissue International
researchProduct

Specific challenges in end-of-life care for patients with hematological malignancies.

2019

Purpose of review The disease-related burden of patients with hematological malignancies is comparable with patients suffering from solid tumors. Palliative care offers relief from suffering independent of type of disease and prognosis. The prevalence of hematological malignancies is expected to increase in the next 20 years because of better therapeutic options with longer survival and because of the aging population. However, patients with hematological malignancies are underrepresented in palliative care as these diseases are associated with special care needs and prognostic uncertainty, which differ from the unambiguity of terminally ill patients with solid tumors. This review describes…

Advance care planningmedicine.medical_specialtyPalliative caremedicine.medical_treatmentHealth StatusMEDLINEHematopoietic stem cell transplantationDiseaseComorbidityCritical Care and Intensive Care Medicine03 medical and health sciencesAdvance Care Planning0302 clinical medicineMedicineHumans030212 general & internal medicineIntensive care medicineQualitative ResearchTerminal CareOncology (nursing)business.industryPalliative CareHematopoietic Stem Cell TransplantationUncertaintyGeneral Medicinemedicine.diseasePrognosisComorbidity3. Good health030228 respiratory systemOncologyCaregiversHematologic NeoplasmsInterdisciplinary CommunicationbusinessEnd-of-life careQualitative researchCurrent opinion in supportive and palliative care
researchProduct

Terminal nerve in the mouse-eared bat (Myotis myotis): ontogenetic aspects.

2006

As in other mammals, ontogenesis of the terminal nerve (TN) in the mouse-eared bat (Myotis myotis) starts shortly after the formation of the olfactory placode, a derivative of the ectoderm. During development of the olfactory pit, proliferating neuroblasts thicken the placodal epithelium and one cell population migrates toward the rostroventral tip of the telencephalon. Here they accumulate in a primordial terminal ganglion, which successively divides into smaller units. Initial fibers of the TN can be distinguished from olfactory fibers in the mid-embryonic period. The main TN fiber bundle (mfb) originates from the anteriormost ganglion in the nasal roof, whereas one or more inconstant sma…

AgingPopulationEctodermMyotis myotisNoseChiropteramedicineAnimalseducationCell ProliferationCell SizeNeuronseducation.field_of_studybiologyCerebrumOlfactory tubercleCranial NervesCell DifferentiationAnatomyOlfactory Pathwaysbiology.organism_classificationAgricultural and Biological Sciences (miscellaneous)Olfactory BulbOlfactory bulbGanglionmedicine.anatomical_structureTerminal nerveAnatomyThe anatomical record. Part A, Discoveries in molecular, cellular, and evolutionary biology
researchProduct

ADAM-10 over-expression increases cortical synaptogenesis.

2006

Cortical cholinergic, glutamatergic and GABAergic terminals become upregulated during early stages of the transgenic amyloid pathology. Abundant evidence suggests that sAPP alpha, the product of the non-amyloidogenic alpha-secretase pathway, is neurotrophic both in vitro and when exogenously applied in vivo. The disintegrin metalloprotease ADAM-10 has been shown to have alpha-secretase activity in vivo. To determine whether sAPP alpha has an endogenous biological influence on cortical presynaptic boutons in vivo, we quantified cortical cholinergic, glutamatergic and GABAergic presynaptic bouton densities in either ADAM-10 moderate expressing (ADAM-10 mo) transgenic mice, which moderately ov…

Agingmedicine.medical_specialtySynaptogenesisPresynaptic TerminalsAlpha (ethology)Mice TransgenicBiologyReceptors Metabotropic GlutamateGlutamatergicADAM10 ProteinMiceReceptors GABAInternal medicinemedicineAnimalsHumansReceptors CholinergicCerebral CortexGeneral NeuroscienceGene Expression Regulation DevelopmentalMembrane Proteinscarbohydrates (lipids)ADAM Proteinsmedicine.anatomical_structureEndocrinologyCerebral cortexSynaptic plasticitySynapsesbiology.proteinGABAergicCholinergicCattleNeurology (clinical)Geriatrics and GerontologyAmyloid Precursor Protein SecretasesDevelopmental BiologyNeurotrophinNeurobiology of aging
researchProduct

Perinatal exposure to 5-methoxytryptamine, behavioural-stress reactivity and functional response of 5-HT1A receptors in the adolescent rat.

2008

Abstract Serotonin is involved in a wide range of physiological and patho-physiological mechanisms. In particular, 5-HT1A receptors are proposed to mediate stress-adaptation. The aim of this research was to investigate in adolescent rats: first, the consequences of perinatal exposure to 5-metoxytryptamine (5MT), a 5-HT1/5-HT2 serotonergic agonist, on behavioural-stress reactivity in elevated plus maze, open field and forced swim tests; secondly, whether the behavioural effects induced by perinatal exposure to 5MT on open field and forced swim tests were affected by the selective 5-HT1A receptor agonist LY 228729, a compound able to elicit a characteristic set of motor behaviours on these ex…

AgonistMalemedicine.medical_specialtyElevated plus mazePerinatal 5MTOffspringmedicine.drug_classPyridinesPresynaptic TerminalsAnxietyMotor ActivitySerotonergicOpen fieldPiperazinesStatistics Nonparametric5-MethoxytryptamineBehavioral NeuroscienceSerotonin AgentsSex FactorsPregnancyBehavioural-stress reactivityInternal medicinemedicineAdolescent ratAnimals5-HT1A receptorErgolinesRats WistarAnalysis of VariancePerinatal 5MT; 5-HT1A receptors; Acute LY 228729 and WAY 100635; Behavioural-stress reactivity; Adolescent ratPerinatal ExposureBrainDrug SynergismRatsEndocrinologyAnimals NewbornPrenatal Exposure Delayed EffectsReceptor Serotonin 5-HT1ASynapsesSettore BIO/14 - FarmacologiaExploratory BehaviorAcute LY 228729 and WAY 100635FemaleSerotoninPsychologyStress PsychologicalBehavioural despair testBehavioural brain research
researchProduct

Regulation of the effects of CYP2E1-induced oxidative stress by JNK signaling

2014

The generation of excessive amounts of reactive oxygen species (ROS) leads to cellular oxidative stress that underlies a variety of forms of hepatocyte injury and death including that from alcohol. Although ROS can induce cell damage through direct effects on cellular macromolecules, the injurious effects of ROS are mediated largely through changes in signal transduction pathways such as the mitogen-activated protein kinase c-Jun N-terminal kinase (JNK). In response to alcohol, hepatocytes have increased levels of the enzyme cytochrome P450 2E1 (CYP2E1) which generates an oxidant stress that promotes the development of alcoholic steatosis and liver injury. These effects are mediated in larg…

Alcoholic liver diseaseClinical BiochemistryReview ArticleMitogen-activated protein kinase kinasemedicine.disease_causeBiochemistryCytochrome P450 2E10302 clinical medicineMolecular Targeted TherapyMitogen-activated protein kinaseslcsh:QH301-705.5c-Jun N-terminal kinasechemistry.chemical_classificationTNF tumor necrosis factorlcsh:R5-9200303 health sciencesCell DeathCYP2E1 cytochrome P450 2E1Cytochrome P-450 CYP2E13. Good healthCell biologyPKD protein kinase DLiverJNK c-Jun N-terminal kinaseSab SH3 homology associated BTK binding protein030211 gastroenterology & hepatologySignal transductionlcsh:Medicine (General)MAP Kinase Signaling SystemAPAP acetaminophenMKK MAPK kinaseBiology03 medical and health sciencesROS reactive oxygen speciesPKC protein kinase CmedicineAnimalsHumansMAPKKK MAPK kinase kinaseProtein kinase ACell damage030304 developmental biologyReactive oxygen speciesMAP kinase kinase kinaseOrganic ChemistryJNK Mitogen-Activated Protein KinasesAlcoholic liver diseasemedicine.diseaseERK1/2 extracellular signal-regulated kinase 1/2Fatty Liverlcsh:Biology (General)chemistryOxidative stressNAFLD nonalcoholic fatty liver diseaseReactive Oxygen SpeciesMAPK mitogen-activated protein kinaseOxidative stressRedox Biology
researchProduct